Picture of OraSure Technologies logo

OSUR OraSure Technologies Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Momentum

Relative Strength (%)
1m-9.12%
3m-18.86%
6m-21.8%
1yr-47.53%
Volume Change (%)
10d/3m-48.24%
Price vs... (%)
52w High-46.51%
50d MA-11.13%
200d MA-23.42%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-6.33%
Return on Equity-4.64%
Operating Margin-15.2%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of OraSure Technologies EPS forecast chart

Profile Summary

OraSure Technologies, Inc. provides point-of-care and home diagnostic tests and sample management solutions. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV, Hepatitis C and Syphilis that are performed on a rapid basis at the point of care. Its business also includes sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

Directors

Last Annual
December 31st, 2024
Last Interim
December 31st, 2024
Incorporated
May 5th, 2000
Public Since
November 17th, 1986
No. of Shareholders
22,476
No. of Employees
501
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
77,488,414

OSUR Share Price Performance

Upcoming Events for OSUR

Q1 2025 OraSure Technologies Inc Earnings Release

Q1 2025 OraSure Technologies Inc Earnings Call

OraSure Technologies Inc Annual Shareholders Meeting

OraSure Technologies Inc Annual Shareholders Meeting

Q2 2025 OraSure Technologies Inc Earnings Release

Similar to OSUR

Picture of 10X Genomics logo

10X Genomics

us flag iconNASDAQ Global Select Market

Picture of Accuray logo

Accuray

us flag iconNASDAQ Global Select Market

Picture of Akoya Biosciences logo

Akoya Biosciences

us flag iconNASDAQ Global Select Market

Picture of Align Technology logo

Align Technology

us flag iconNASDAQ Global Select Market

Picture of Alphatec Holdings logo

Alphatec Holdings

us flag iconNASDAQ Global Select Market

FAQ